What Nobel Laureate Dr. Jim Allison’s Story Can Teach Entrepreneurs and Innovators
Jim Allison shared the Nobel Prize in Physiology or Medicine in 2018, along with Tasuku Hanjo, for pioneering the use of immune checkpoint inhibitors to develop cancer therapies.
Allison’s remarkable and groundbreaking research into T-Cell activation, and his subsequent work developing his discoveries into viable cancer treatment, has extended the lives of thousands of cancer patients. Allison’s work is more than remarkable: It represents an earth-shaking paradigm shift in scientific thought about how cancer works and could be defeated.